Please login to the form below

Not currently logged in
Email:
Password:

Cancer Research

This page shows the latest Cancer Research news and features for those working in and with pharma, biotech and healthcare.

AZ to address Imfinzi setback, but sees potential with Tagrisso

AZ to address Imfinzi setback, but sees potential with Tagrisso

At the American Association for Cancer Research (AACR) Meeting in Atlanta, US, AZ intends to address Imfinzi’s latest setback as a first-line therapy in metastatic non-small cell lung ... AstraZeneca is continuing to strengthen its portfolio of

Latest news

More from news
Approximately 19 fully matching, plus 329 partially matching documents found.

Latest Intelligence

  • Where next in Alzheimer’s disease R&D? Where next in Alzheimer’s disease R&D?

    The work builds on research at the University of Cambridge that discovered a molecule that reduced the production of Abeta in early-stage tests. ... Yet, as the rapid pace of progress in cancer shows, decades of unsung research into disease biology can

  • Bringing life to precision medicine Bringing life to precision medicine

    Harnessing the power of patient-derived organoids. The global cancer burden. Despite enormous investment over recent decades into research and treatment development, cancer remains one of the leading causes of death ... worldwide, with 18.1 million new

  • AstraZeneca’s oncology renaissance AstraZeneca’s oncology renaissance

    The NELSON trial, which looked at screening in Europe, was presented at the recent World Conference on Lung Cancer. ... A drive to do more. Returning to the theme of cancer research, Galbraith says there is still much more progress to be made –

  • Combined immunotherapies – potential and pitfalls Combined immunotherapies – potential and pitfalls

    A recent review of the current landscape of clinical research in cancer immunotherapy counted more than 3, 000 trials enrolling patients, including more than 1, 000 trials evaluating combinations with ... This view is shared by Professor Charles Swanton,

  • AstraZeneca: building a new ‘open innovation’ pharma company AstraZeneca: building a new ‘open innovation’ pharma company

    Open-minded culture. Like the new HQ’s construction, there have been setbacks – such as the setback to its Imfinzi tremelimumab immunotherapy combination in the MYSTIC lung cancer trial last year – ... The park is also home to the Cancer Research

More from intelligence
Approximately 0 fully matching, plus 31 partially matching documents found.

Latest appointments

  • Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

    Under Bahija’s leadership, MedImmune significantly boosted its pipeline, expanding from 40 to more than 130 molecules in research and development targeting cancer; respiratory, inflammation, and autoimmunity; cardiovascular, renal and metabolic;

  • José Baselga joins BMS’ board of directors José Baselga joins BMS’ board of directors

    Dr Baselga is currently the physician in chief at Memorial Sloan Kettering Cancer Center, where he is responsible for the management of patients care, enhancing and expanding programmes in clinical and ... Association for Cancer Research.

  • Glythera strengthens its scientific advisory board and appoints CSO Glythera strengthens its scientific advisory board and appoints CSO

    Dr Lutz was previously vice president of translation research and development at ImmunoGen, where he was responsible for all early-stage ADC development programmes. ... Additionally, Dr Jon Roffey joins Glythera’s scientific advisory board (SAB) from

  • Lilly bolsters its oncology team Lilly bolsters its oncology team

    cancer programme, associate director for strategic relations for the Duke Cancer Institute among other roles. ... cancer research, especially metastatic breast cancer, where she has led programmes that resulted in numerous ground-breaking regulatory

  • Storm Therapeutics strengthens its board Storm Therapeutics strengthens its board

    Workman currently serves The Institute of Cancer Researc h as its president and chief executive officer and has formerly served as head of the division of cancer therapeutics at Cancer Research ... world class cancer institute and being a founder of

More from appointments
Approximately 1 fully matching, plus 30 partially matching documents found.

Latest from PMHub

  • Qualitative segmentation validation study with backroom brainstorm exercises

    Our client had an oncology product in development for the treatment of prostate cancer. ... The company wanted to conduct research to inform future planning, list development, advisory board creation, and initial communications platforms.

  • International Childhood Cancer Day 2019

    We've pulled together an infographic to show just what we mean with data c/o Cancer Research UK (CRUK) and a great initiative by Beads of Courage, Inc. ... There's still more to do, so show your support for a day when there is No More Pain and No More

  • Maker Projects

    Our clients include: The NHS NWEH Cancer Research Cosentyx / Novartis Brilinta / AstraZeneca Port of Call We have branches in Manchester and London - to find out more: www.makerprojects.co.

  • A reflection of ESMO

    The objective for this congress is for HCPs to learn from physicians and scientists who present their research in prostate, bladder, and kidney cancer. ... highlighting the ground-breaking research in cancer care.

  • Artificial Intelligence in Healthcare

    Closer to home, scientists at the Institute of Cancer Research (ICR), in collaboration with colleagues from the University of Edinburgh, recently developed a machine-learning method that enabled the prediction of ... trust the same digital system to

More from PMHub
Approximately 1 fully matching, plus 27 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics